111 Capital Invests $424,000 in Bath & Body Works, Inc. (NYSE:BBWI)

111 Capital acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 10,948 shares of the company's stock, valued at approximately $424,000.

Other institutional investors have also recently added to or reduced their stakes in the company. D1 Capital Partners L.P. purchased a new stake in shares of Bath & Body Works in the 4th quarter worth about $109,797,000. Norges Bank purchased a new stake in shares of Bath & Body Works in the fourth quarter valued at about $73,572,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Bath & Body Works by 79.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company's stock valued at $150,507,000 after purchasing an additional 1,715,096 shares in the last quarter. Alliancebernstein L.P. increased its stake in shares of Bath & Body Works by 35.6% during the 4th quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company's stock worth $200,768,000 after purchasing an additional 1,360,264 shares in the last quarter. Finally, Anomaly Capital Management LP increased its stake in shares of Bath & Body Works by 38.3% during the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock worth $188,456,000 after purchasing an additional 1,346,752 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on BBWI shares. Raymond James reduced their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research note on Thursday, April 17th. Barclays decreased their price objective on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a research note on Friday. Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. UBS Group upped their target price on shares of Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. Finally, Wells Fargo & Company raised their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 14th. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $42.00.

Bath & Body Works Stock Performance

Bath & Body Works stock traded down $1.13 during trading on Monday, reaching $26.99. The company had a trading volume of 5,819,105 shares, compared to its average volume of 5,004,760. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99. The stock's 50 day moving average price is $30.07 and its two-hundred day moving average price is $33.97. The firm has a market capitalization of $5.75 billion, a price-to-earnings ratio of 6.60, a PEG ratio of 0.92 and a beta of 1.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same quarter last year, the business earned $0.38 EPS. Bath & Body Works's revenue for the quarter was up 2.9% on a year-over-year basis. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.96%. The ex-dividend date is Friday, June 6th. Bath & Body Works's dividend payout ratio (DPR) is presently 21.33%.

Bath & Body Works declared that its board has authorized a stock repurchase plan on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.